fda restrictions bpc-157 compounding I am getting so many messages Repost @peptides with @use.repost ・・・

Repost @peptides with @use.repost BREAKING NEWS! Today's 86 advisory vote for BPC 157 is one of the biggest peptide regulatory developments we've seen in years. While nothing changes immediately, the recommendation represents FDA's Overreach on Compounded Peptides 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval fda restrictions on bpc 157 compounding BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal

SKU: 24782557867 · From www.marsberger-treibhaus.de